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"Our greatest weakness lies in giving up. The most certain way to succeed is always to try just  
one  more  time."  -  Thomas  A.  Edison                                            
Prior  to  1980,  the  only  method  to  treat  cardiac  arrhythmias  besides  anti-arrhythmic  drug 
therapy was open-heart  surgery,  that  involved either  dissecting  or  freezing the arrhythmic 
focus  with  a  hand-held  metal  probe.  Soon  thereafter,  early  reports  of  percutaneously 
performed cardiac ablation were published that marked the beginning of a new era in the field 
of cardiac electrophysiology (EP). As our understanding of EP and ablation physics continues 
to  evolve,  remarkable  advancements  have  been  made  over  the  last  30  years  in  ablation 
technology - moving from direct-current energy in the early 1980s, to radio-frequency (RF) 
ablation,  to  the  more  recent  cryoablation  in  the  last  decade.                           
Accessory pathways (AP) are the commonest reasons for supraventricular tachycardia in the 
pediatric  population.  Antero-septal,  mid-septal,  and para-Hisian AP locations  are  the  least 
common  locations  in  Wolff-Parkinson-White  syndrome  [1-3].  RF  ablation  has  been 
commonly used to treat these APs. Although highly efficacious, septal AP ablation with RF 
carries a high risk of heart block (previously reported to be as high as a 5%) [1,4,5] due close 
anatomic proximity of these APs to the atrio-ventricular (AV) node and the His bundle. As 
such,  the  need  for  a  permanent  pacemaker  is  a  dreaded  complication  of  this  procedure, 
especially in the pediatric population. Cryoablation is an emerging technology that has shown 
to be much safer in this regard for ablating septal APs [6,7].                                 
In this  issue of the  Journal,  Liberman and colleagues  studied 70 patients  who underwent 
cryoablation  for  antero-septal  APs.  Six  of  these  patients  were  identified  to  have  a  His-
electrogram on the cryo catheter at the site of successful AP ablation [8]. All 6 patients had 
evidence of ventricular pre-excitation. Using 4-6 mm tip cryoablation catheters the authors 
report a 100% acute procedural success rate, though disease recurrence was noted in 2 patients 
within 30-days that necessitated a second ablation procedure. While intra-procedural transient 
AV block and A-H prolongation occurred in two patients, no patients had high-grade heart 
block during a median follow-up of 13 months. The authors concluded that antero-septal APs 
can be safely and successfully ablated using cryo energy even when a His bundle electrogram 
is  recorded  from  the  tip  of  the  ablation  catheter.                                
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The authors must be commended for conducting and reporting such a study as it would be 
highly unusual for electrophysiologists to deliver ablation lesions at an area where a discrete 
His-electrogram can be identified - unless intended for the purpose of intentional AV nodal 
ablation. While the findings are interesting, a few limitations must be addressed. First, it is 
difficult to ascertain whether the His signal noted at the ablation site was a near- or far-field 
electrogram. Given that cryo lesions are focused and shallow, it is likely that presence of a low 
frequency/  far  field  His  signal  may have  been protective.  Second,  'slants'  have  also  been 
described in  antero-septal  APs  [9].  Differential  pacing  form right  atrial  appendage versus 
lateral coronary sinus, may unfold other alternative sites, probably away from the His location, 
with an AP potential  that would be good ablation targets.  Third is  the sample size of six 
patients.  
Nevertheless, these findings advance our knowledge and complement the findings previously 
published. Prior reports have consistently shown that cryoablation for substrate targets that are 
in close proximity to the AV node, is associated with a significantly lower incidence of heart 
block as compared to traditional RF ablation [10]. In a large systematic review [11], Atienza 
and colleagues  reported the procedural results  of 3,775 patients  who underwent septal  AP 
ablation using either cryo or RF energy. While the incidence of complete heart block was 
2.8% with RF, there were no cases of persistent AV nodal injury with cryoablation.            
Several speculations can be made as to why cryoablation may be safer in this regard. First, 
cryoablation has the advantage of helping to localize the site of an AP using the technique of 
'cryo-mapping'  [6] in  which selected  sites are  cooled  to a  temperature  that  reversibly and 
temporarily  halts  local  electrical  activity,  but  not  to  a  temperature  low  enough  to  cause 
permanent tissue damage [12,13] While it does not appear that cryo-mapping was performed 
in these 6 patients; this strategy should be routinely employed during such high-risk ablations. 
Second, once a critical  freezing temperature is reached, the cryo catheters do not move in 
reference to cardiac and respiratory motion unlike RF catheters. It is important to remember 
that APs are, generally, very small discrete structures. Although cryo and RF lesions create 
lesions of equal depth,  the endocardial  surface affected by cryo is smaller due to catheter 
stability, yielding a smaller volume of ablated tissue [14]. Cryo lesions are, therefore, more 
'focused'  and  ideal  for  targeting  small  APs  without  injury  to  nearby  structures.  Lastly, 
application of RF around the AV node frequently provokes junctional rhythm that can make 
the assessment of antegrade AV conduction during ablation slightly challenging. The other 
method of checking AV node integrity is by assessment of retrograde VA conduction. In such 
cases situations however, even when RF application is halted with first signs of retrograde VA 
block, severe heart block may occur and usually persist. During cryoablation it is uncommon 
to see junctional rhythm [6,13], and thus antegrade AV conduction can be easily monitored 
with atrial  pacing during ablation as done in the present study by Liberman et al.         
Despite  the  beneficial  safety  profile,  procedural  success  rates  with  cryoablation  remain 
suboptimal as compared to RF [11,15]. Even in the present study 2/6 (33%) patients had early 
disease  recurrence  requiring  a  redo  ablation.  However,  in  young  patients  who  require 
perinodal AP ablation,  cryoablation with cryo-mapping can be used as a reasonable initial 
strategy,  especially  when  one  is  willing  to  accept  a  lower  rate  of  procedural  success  to 
minimize the risk of procedural AV block. If unsuccessful, RF ablation can be pursued. As far 
as ablating an AP at a site of the His electrogram is concerned, studies with larger sample sizes 
are required to assess procedural safety and future implementation of such a strategy into 
clinical  practice.                                          
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